An EBV-positive lymphoproliferative disorder after therapy with alemtuzumab.
Journal Article (Letter)
Full Text
Duke Authors
Cited Authors
- Ghobrial, IM; Otteman, LA; White, WL
Published Date
- December 25, 2003
Published In
Volume / Issue
- 349 / 26
Start / End Page
- 2570 - 2572
PubMed ID
- 14695424
Pubmed Central ID
- 14695424
Electronic International Standard Serial Number (EISSN)
- 1533-4406
Digital Object Identifier (DOI)
- 10.1056/NEJM200312253492622
Language
- eng
Conference Location
- United States